Prof. Dr. Sebahattin YURDAKUL

Yayın Ağı

Makaleler 149

1. Infliximab for vascular involvement in Behcet's syndrome

HATEMİ G., Tukek N. B., ESATOĞLU S. N., ÖZGÜLER Y., Taflan S. S., UYGUNOĞLU U., et al.

CLINICAL IMMUNOLOGY , cilt.253, 2023 (SCI-Expanded)

2. Frequency of AA amyloidosis has decreased in Behcet's syndrome: a retrospective study with long-term follow-up and a systematic review Amyloidosis in Behcet's syndrome

Karatemiz G., ESATOĞLU S. N., Gurcan M., ÖZGÜLER Y., Yurdakul S., HAMURYUDAN V., et al.

RHEUMATOLOGY , cilt.62, ss.9-18, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

3. Outcome of Vascular Involvement of Behcet Syndrome Treated with Infliximab: A Retrospective Cohort Study

HATEMİ G., Tukek N. B., ESATOĞLU S. N., ÖZGÜLER Y., Taflan S. S., MELİKOĞLU M., et al.

ARTHRITIS & RHEUMATOLOGY , ss.3098-3099, 2022 (SCI-Expanded, Scopus)

4. Screening for latent tuberculosis before starting TNF-alpha inhibitors in a population with high BCG vaccination rates

Hacioglu A., BÖREKÇİ Ş., MELİKOĞLU M., ÖZGÜLER Y., Esatoglu S. N., UĞURLU S., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.42, sa.8, ss.1443-1451, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. Emergence of new manifestations during infliximab treatment in Behcet's syndrome

TÜKEK N. B., ESATOĞLU S. N., HATEMİ G., Caliskan E. B., Ozyazgan Y., UÇAR D., et al.

RHEUMATOLOGY , cilt.61, sa.9, ss.3746-3753, 2022 (SCI-Expanded, Scopus)

6. OUTCOME OF VASCULAR INVOLVEMENT OF BEHCET'S SYNDROME TREATED WITH INFLIXIMAB: A RETROSPECTIVE COHORT STUDY

Hatemi G., Tukek B., Esatoglu S. N., Ozguler Y., Taflan S. S., Melikoglu M., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.696-697, 2022 (SCI-Expanded)

7. MYCOPHENOLATE FOR THE TREATMENT OF EYE INVOLVEMENT IN PATIENTS WITH BEHCET'S SYNDROME

Ucar D., Ozyazgan Y., Esatoglu S. N., Cerme E., Hamuryudan V., Melikoglu M., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1760-1761, 2022 (SCI-Expanded, Scopus)

8. DRUG SURVIVAL OF INFLIXIMAB IN BEHCET'S SYNDROME PATIENTS WITH DIFFERENT TYPES OF INVOLVEMENT

Esatoglu S. N., Tukek B., Taflan S. S., Ozyazgan Y., Ucar D., Hamuryudan V., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.697-698, 2022 (SCI-Expanded, Scopus)

9. A SYSTEMATIC REVIEW OF AA AMYLOIDOSIS AMONG PATIENTS WITH BEHCET'S SYNDROME

Karatemiz G., Esatoglu S. N., Gurcan M., Ozguler Y., Yurdakul S., Hamuryudan V., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1758-1759, 2022 (SCI-Expanded, Scopus)

10. CAUSES OF HOSPITALIZATION IN BEHCET SYNDROME

Ozguler Y., Hatemi G., Pala A. S., Esatoglu S. N., UĞURLU S., SEYAHİ E., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.958, 2021 (SCI-Expanded)

11. EMERGENCE OF DE NOVO MANIFESTATIONS DURING INFLIXIMAB TREATMENT IN BEHCET SYNDROME

Tukek B., Esatoglu S. N., Hatemi G., Caliskan E. B., Ozyazgan Y., Ucar D., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.662-663, 2021 (SCI-Expanded, Scopus)

12. INFLIXIMAB FOR VASCULAR INVOLVEMENT IN BEHCET SYNDROME

Hatemi G., Tukek B., Esatoglu S. N., Ozguler Y., Melikoglu M., Caliskan E. B., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.663, 2021 (SCI-Expanded)

13. DRUG RETENTION RATE, REASONS FOR DISCONTINUATION AND OUTCOME OF INFLIXIMAB USE IN BEHCET SYNDROME

Esatoglu S. N., Tukek B., Taflan S. S., Ozyazgan Y., Ucar D., Hamuryudan V., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.660-661, 2021 (SCI-Expanded, Scopus)

14. Long term follow-up of Behcet's syndrome patients treated with cyclophosphamide

Gurcan M., Esatoglu S. N., HAMURYUDAN V., Saygin D., UĞURLU S., SEYAHİ E., et al.

RHEUMATOLOGY , cilt.59, sa.9, ss.2264-2271, 2020 (SCI-Expanded)

15. Surgical Treatment of Pulmonary Complications in Behcet's Syndrome

Tuzun H., Seyahi E., Guzelant G., Oz B., Batur S., Demirhan O., et al.

SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY , cilt.30, sa.3, ss.369-378, 2018 (SCI-Expanded, Scopus)

16. Retrospective Analysis of Initial Presentation Findings of Behcet's Syndrome throughout 4 Decades

Dincses E., Ozguler Y., Ucar D., Ozyazgan Y., Ugurlu S., Hatemi G., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded)

17. Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studies

Ayan G., Esatoglu S. N., Hatemi G., Ugurlu S., Seyahi E., Melikoglu M., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.38, sa.4, ss.607-622, 2018 (SCI-Expanded, Scopus)

18. Considerations in designing and interpreting prevalence studies for Behcet syndrome

Hatemi G., Esatoglu S. N., Yurdakul S.

POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ , cilt.128, sa.3, ss.148-149, 2018 (SCI-Expanded, Scopus)

19. Clinical efficacy and safety of a new 1000-mg suspension versus twice-daily 500-mg tablets of MPFF in patients with symptomatic chronic venous disorders: a randomized controlled trial

Carpentier P., van Bellen B., Karetova D., Hanafiah H., Enriquez-Vega E., Kirienko A., et al.

INTERNATIONAL ANGIOLOGY , cilt.36, sa.5, ss.402-409, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

20. Surgical Therapies in the Treatment of Pulmonary Artery Involvement in Behcet's Syndrome

Tuzun H., Guzelant G., Demirhan O., Oz B., Fresko I., Hamuryudan V., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded, Scopus)

21. FACTORS AFFECTING QUALITY OF LIFE AFTER BYPASS GRAFTING IN CRITICAL LEG ISCHEMIA

Sipahioglu N. T., Arslan C., Can G., Tuzun H., Sipahioglu F.

NOBEL MEDICUS , cilt.13, sa.2, ss.52-56, 2017 (ESCI, Scopus)

22. a Systematic Literature Review on the Treatment of Skin, Mucosa and Joint Involvement of BehcEt's Syndrome Informing the Eular Recommendations for the Management of BehcEt's Syndrome

Leccese P., Ozguler Y., Christensen R., Esatoglu S. N., Bang D., Bodaghi B., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus)

23. Fatigue is correlated with disease activity but not with the type of organ involvement in Behcet's syndrome: a comparative clinical survey

Buyuktas D., Hatemi G., Yuksel-Findikoglu S., Ugurlu S., Yazici H., Yurdakul S.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.33, sa.6, 2015 (SCI-Expanded, Scopus)

24. An outcome survey of 43 patients with Budd-Chiari syndrome due to Behcet's syndrome followed up at a single, dedicated center

Seyahi E., Caglar E., Ugurlu S., Kantarci F., Hamuryudan V., Sonsuz A., et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.44, sa.5, ss.602-609, 2015 (SCI-Expanded, Scopus)

25. Budd-Chiari Syndrome Due to Behcet's Syndrome: Some Patients Present without Liver Related Symptoms and Have a Better Outcome.

Seyahi E., Caglar E., Ugurlu S., Kantarci F., Hamuryudan V., Sonsuz A., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus)

26. Anti-TNF Treatment for Refractory Vascular Involvement of Behcet's Syndrome.

Hamuryudan V., Seyahi E., Melikoglu M., Ugurlu S., Hatemi G., Yurdakul S., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus)

27. Inadequate Description and Discussion of Enrolled Patient Characteristics and Potential Inter-Study Site Differences in Reports of Randomized Controlled Trials: A Systematic Survey in Six Rheumatology Journals

Yurdakul S., Mustafa B. N., Fresko I., Seyahi E., Yazici H.

ARTHRITIS & RHEUMATOLOGY , cilt.66, sa.5, ss.1395-1399, 2014 (SCI-Expanded, Scopus)

28. Colchicine in Behcet Syndrome: A Longterm Survey of Patients in a Controlled Trial

Hamuryudan V., Hatemi G., Tascilar K., Yurdakul S., Mat C., Ozyazgan Y., et al.

JOURNAL OF RHEUMATOLOGY , cilt.41, sa.4, ss.735-738, 2014 (SCI-Expanded, Scopus)

29. LONG-TERM TREATMENT RESULTS IN SOFT TISSUE SARCOMAS OF THE THORACIC WALL TREATED BY PRE-OR-POSTOPERATIVE RADIOTHERAPY IN A MULTIDISCIPLINARY APPROACH-RESULTS OF THE CTF SARCOMA GROUP

Dincbas H. F., Mandel N., Ozdemir S., Kaydihan N., Oksuz D. C., Dervisoglu S., et al.

JOURNAL OF THORACIC ONCOLOGY , cilt.8, 2013 (SCI-Expanded, Scopus)

30. Aortic and coronary calcifications in Takayasu arteritis

Seyahi E., Ucgul A., Olgun D. C., Ugurlu S., Akman C., Tutar O., et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.43, sa.1, ss.96-104, 2013 (SCI-Expanded)

31. Behcet's syndrome: Facts and controversies

Mat C., Yurdakul S., Sevim A., Ozyazgan Y., Tuzun Y.

CLINICS IN DERMATOLOGY , cilt.31, sa.4, ss.352-361, 2013 (SCI-Expanded, Scopus)

32. Canakinumab in a patient with juvenile Behcet's syndrome with refractory eye disease

Ugurlu S., Ucar D., Seyahi E., Hatemi G., Yurdakul S.

ANNALS OF THE RHEUMATIC DISEASES , cilt.71, sa.9, ss.1591-1592, 2012 (SCI-Expanded, Scopus)

33. Frequent oral ulceration during early disease may predict a severe disease course in males with Behcet's syndrome

Hamuryudan V., Hatemi G., Sut N., Ugurlu S., Yurdakul S., Yazici H.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.30, sa.3, 2012 (SCI-Expanded, Scopus)

34. Pulmonary Artery Involvement and Associated Lung Disease in Behcet Disease A Series of 47 Patients

Seyahi E., Melikoglu M., Akman C., Hamuryudan V., Ozer H., Hatemi G., et al.

MEDICINE , cilt.91, sa.1, ss.35-48, 2012 (SCI-Expanded, Scopus)

35. Should immunosuppressives be stopped in granulomatosis with polyangiitis (Wegener's granulomatosis) patients undergoing dialysis?

Buyuktas D., Hatemi G., Tascilar K., Fresko I., Yurdakul S.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.30, sa.1, 2012 (SCI-Expanded, Scopus)

36. COLCHICINE DOES NOT DECREASE THE NEED FOR IMMUNOSUPPRESSIVE USE AT LONG TERM IN BEHCET'S SYNDROME (BS)

Hamuryudan V., Hatemi G., Yurdakul S., Tascilar K., Mat C., Ozyazgan Y., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded)

37. EYE DISEASE IN JUVENILE PATIENTS WITH BEHCET'S SYNDROME

Ozyazgan Y., Seyahi E., Sarica A., Ugurlu S., Hatemi G., Yurdakul S., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded)

38. EFFICACY AND SAFETY OF TNF-ALPHA ANTAGONISTS IN THE MANAGEMENT OF BEHCET'S SYNDROME: A SYSTEMATIC REVIEW

Hatemi G., Hamuryudan V., Yurdakul S., Yazici H.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)

39. CURRENT TRENDS IN THE MANAGEMENT OF BEHCET'S SYNDROME

Hatemi G., Hamuryudan V., Tascilar K., Yurdakul S., Fresko I., Melikoglu M., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)

40. Epidemiology of Behcet's Syndrome and Regional Differences in Disease Expression

Yurdakul S., Yazici Y.

BEHCET'S SYNDROME , ss.35-52, 2010 (SCI-Expanded)

41. Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial

Hamuryudan V., Hatemi G., Tascilar K., Sut N., Ozyazgan Y., Seyahi E., et al.

RHEUMATOLOGY , cilt.49, sa.1, ss.173-177, 2010 (SCI-Expanded, Scopus)

42. Reply to letter by Priori et al commenting on whether Behcet's syndrome patients with acne and arthritis comprise a true subset

Hatemi G., Fresko I., Yurdakul S., Ozdogan H., Yazici H., Altiok E., et al.

ARTHRITIS AND RHEUMATISM , cilt.62, sa.1, ss.305-306, 2010 (SCI-Expanded, Scopus)

43. Locomotor System Disease in Behcet's Syndrome

Yurdakul S., Hatemi G.

BEHCET'S SYNDROME , ss.149-163, 2010 (SCI-Expanded)

44. Management of Behcet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behcet disease

Hatemi G., Silman A., Bang D., Bodaghi B., Chamberlain A. M., Gül A., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.68, sa.10, ss.1528-1534, 2009 (SCI-Expanded, Scopus)

45. Efficacy and safety of TNF-alpha antagonists in the management of Behcet's syndrome - a systematic survey

Hatemi G., Hamuryudan V., Yurdakul S., Yazici H.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.27, sa.5, ss.736, 2009 (SCI-Expanded)

46. EULAR recommendations for the management of Behcet disease

Hatemi G., Silman A., Bang D., Bodaghi B., Chamberlain A. M., Gül A., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.67, sa.12, ss.1656-1662, 2008 (SCI-Expanded)

47. Behcet's Syndrome Is Not So Rare: Why Do We Need to Know?

Yazici H., Seyahi E., Yurdakul S.

ARTHRITIS AND RHEUMATISM , cilt.58, sa.12, ss.3640-3643, 2008 (SCI-Expanded, Scopus)

48. Behcet's syndrome

Yurdakul S., Yazici H.

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY , cilt.22, sa.5, ss.793-809, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

49. Atherosclerosis in Behcet's syndrome

Seyahi E., Ugurlu S., Cumali R., Balci H., Ozdemir O., Melikoglu M., et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.38, sa.1, ss.1-12, 2008 (SCI-Expanded, Scopus)

50. Relapsing polychondritis in a patient with familial Mediterranean fever and amyloidosis

Salihoglu A., Seyahi E., Celik S., Yurdakul S.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.4, 2008 (SCI-Expanded, Scopus)

51. THE LONG TERM PROGNOSIS OF BEHCET'S SYNDROME AMONG MEN WITH SKIN-MUCOSA INVOLVEMENT AT ONSET: RE-EVALUATION OF A COHORT OF PATIENTS ENROLLED IN A CONTROLLED TRIAL

Hamuryudan V., Hatemi G., Tascilar K., Ozyazgan Y., Seyahi E., Mat C., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.4, 2008 (SCI-Expanded)

52. EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF BEHCET'S DISEASE: REPORT OF A TASK FORCE OF THE EUROPEAN STANDING COMMITTEE FOR INTERNATIONAL CLINICAL STUDIES INCLUDING THERAPEUTICS (ESCISIT)

Hatemi G., Silman A., Bang D., Bodaghi B., Chamberlain A. M., Gul A., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.4, 2008 (SCI-Expanded, Scopus)

53. MANAGEMENT OF BEHCET'S DISEASE: A SYSTEMATIC LITERATURE REVIEW FOR THE EULAR EVIDENCE BASED RECOMMENDATIONS FOR THE MANAGEMENT OF BEHCET'S DISEASE

Hatemi G., Silman A., Bang D., Bodaghi B., Chamberlain A. M., Gul A., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.4, 2008 (SCI-Expanded, Scopus)

54. A cost analysis of Behcet's syndrome in Turkey

Sut N., Seyahi E., Yurdakul S., Senocak M., Yazici H.

RHEUMATOLOGY , cilt.46, sa.4, ss.678-682, 2007 (SCI-Expanded)

55. Behcet's syndrome: disease manifestations, management, and advances in treatment

Yazici H., Fresko I., Yurdakul S.

NATURE CLINICAL PRACTICE RHEUMATOLOGY , cilt.3, sa.3, ss.148-155, 2007 (SCI-Expanded, Scopus)

56. Atherosclerosis in Takayasu arteritis

Seyahi E., Ugurlu S., Cumali R., Balci H., Seyahi N., Yurdakul S., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.65, sa.9, ss.1202-1207, 2006 (SCI-Expanded, Scopus)

57. Prevalence of rheumatoid arthritis

Yurdakul S.

JOURNAL OF RHEUMATOLOGY , cilt.33, sa.8, ss.1710, 2006 (SCI-Expanded, Scopus)

58. The frequency of scarring after genital ulcers in Behcet's syndrome: a prospective study

Mat M. C., Goksugur N., Engin B., Yurdakul S., Yazici H.

INTERNATIONAL JOURNAL OF DERMATOLOGY , cilt.45, sa.5, ss.554-556, 2006 (SCI-Expanded, Scopus)

59. A double-blind trial of depot corticosteroids in Behcet's syndrome

Mat C., Yurdakul S., Uysal S., Gogus F., Ozyazgan Y., Uysal O., et al.

RHEUMATOLOGY , cilt.45, sa.3, ss.348-352, 2006 (SCI-Expanded, Scopus)

60. Fibrinolytic activity and d-dimer levels in Behcet's syndrome

Yurdakul S., Hekim N., Soysal T., Fresko I., Bavunoglu I., Ozbakir F., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.23, sa.4, 2005 (SCI-Expanded, Scopus)

61. Short-term trial of etanercept in Behcet's disease: A double blind, placebo controlled study

Melikoglu M., Fresko I., Mat C., Ozyazgan Y., Gogus F., Yurdakul S., et al.

JOURNAL OF RHEUMATOLOGY , cilt.32, sa.1, ss.98-105, 2005 (SCI-Expanded)

62. Infliximab and primary Sjogren's syndrome: Comment on the article by Mariette et al

Fresko I., Seyahi E., Yurdakul S.

ARTHRITIS AND RHEUMATISM , cilt.50, sa.12, ss.4077, 2004 (SCI-Expanded, Scopus)

63. Pulmonary artery aneurysms in Behcet syndrome

Hamuryudan V., Er T., Seyahi E., Akman C., Tuzun H., Fresko I., et al.

AMERICAN JOURNAL OF MEDICINE , cilt.117, sa.11, ss.867-870, 2004 (SCI-Expanded)

64. Coronary atherosclerosis in Behcet's syndrome: a pilot study using electron-beam computed tomography

Seyahi E., Memisoglu E., Hamuryudan V., Tepe S., Aker U., Balci H., et al.

RHEUMATOLOGY , cilt.43, sa.11, ss.1448-1450, 2004 (SCI-Expanded, Scopus)

65. The long-term mortality and morbidity of Behcet syndrome - A 2-decade outcome survey of 387 patients followed at a dedicated center

Kural-Seyahi E., Fresko I., Seyahi N., Ozyazgan Y., Mat C., Hamuryudan V., et al.

MEDICINE , cilt.82, sa.1, ss.60-76, 2003 (SCI-Expanded)

66. Interferon alfa combined with azathioprine for the uveitis of Behcet's disease: An open study

Hamuryudan V., Ozyazgan Y., Fresko Y., Mat C., Yurdakul S., Yazici H.

ISRAEL MEDICAL ASSOCIATION JOURNAL , cilt.4, sa.11, ss.928-930, 2002 (SCI-Expanded, Scopus)

67. A double-blind trial of colchicine in Behcet's syndrome

Yurdakul S., Mat C., Tuzun Y., Ozyazgan Y., Hamuryudan V., Uysal O., et al.

ARTHRITIS AND RHEUMATISM , cilt.44, sa.11, ss.2686-2692, 2001 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

68. Papulopustular skin lesions are seen more frequently in patients with Behcet's syndrome who have arthritis: a controlled and masked study

Diri E., Mat C., Hamuryudan V., Yurdakul S., Hizli N., Yazici H.

ANNALS OF THE RHEUMATIC DISEASES , cilt.60, sa.11, ss.1074-1076, 2001 (SCI-Expanded)

69. Anticardiolipin antibodies in Behcet's disease: a reassessment

Tokay S., Direskeneli H., Yurdakul S., Akoglu T.

RHEUMATOLOGY , cilt.40, sa.2, ss.192-195, 2001 (SCI-Expanded, Scopus)

70. A reappraisal of amyloidosis in Behcet's syndrome

Melikoglu M., Altiparmak M., Fresko I., Tunc R., Yurdakul S., Hamuryudan V., et al.

RHEUMATOLOGY , cilt.40, sa.2, ss.212-215, 2001 (SCI-Expanded, Scopus)

71. Secondary amyloidosis in progressive systemic sclerosis

Pamuk G., Pamuk O., Altiparmak M., Tanverdi M., Uygun N., Yurdakul S.

CLINICAL RHEUMATOLOGY , cilt.20, sa.4, ss.285-287, 2001 (SCI-Expanded, Scopus)

72. Intestinal permeability in Behcet's syndrome

Fresko I., Hamuryudan V., Demir M., Hizli N., Sayman H., Melikoglu M., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.60, sa.1, ss.65-66, 2001 (SCI-Expanded, Scopus)

73. Behcet disease

Yazici H., Yurdakul S., Hamuryudan V.

CURRENT OPINION IN RHEUMATOLOGY , cilt.13, sa.1, ss.18-22, 2001 (SCI-Expanded, Scopus)

74. Behçet sendromunda antimikobakteriyal antikorlar

MERT A., ÖZTÜRK R., Sipahi S., FRESKO İ., Aslan M., HAMURYUDAN V., et al.

İnfeksiyon Dergisi(Turkish Journal of Infection) , cilt.13, sa.4, ss.527-529, 1999 (Hakemli Dergi)

75. Neutrophil chemotaxis in Behcet's syndrome

Tüzün B., Tuzun Y., Mat C., Yurdakul S., Hamuryudan V., Yazici H., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.58, sa.10, ss.658, 1999 (SCI-Expanded, Scopus)

76. Evaluation of the Turkish translation of a disease activity form for Behcet's syndrome

Hamuryudan V., Fresko I., Direskeneli H., Tenant M., Yurdakul S., Akoglu T., et al.

RHEUMATOLOGY , cilt.38, sa.8, ss.734-736, 1999 (SCI-Expanded)

77. Phenotypic characteristics of B cells in Behcet's disease: Increased activity in B cell subsets

Eksioglu-Demiralp E., Kibaroglu A., Direskeneli H., Yavuz S., Karsli F., Yurdakul S., et al.

JOURNAL OF RHEUMATOLOGY , cilt.26, sa.4, ss.826-832, 1999 (SCI-Expanded, Scopus)

78. Masked assessment of MRI findings: is it possible to differentiate neuro-Behcet's disease from other central nervous system

Coban O., Bahar S., Akman-Demir G., Tasci B., Yurdakul S., Yazici H., et al.

NEURORADIOLOGY , cilt.41, sa.4, ss.255-260, 1999 (SCI-Expanded, Scopus)

79. Behcet's syndrome - The cerrahpasa experience

Yazici H., Fresko I., Hamuryudan V., Mat C., Melikoglu M., Ozyazgan Y., et al.

RHEUMADERM , cilt.455, ss.135-140, 1999 (SCI-Expanded, Scopus)

80. Fibromyalgia in Behcet's syndrome

Yavuz S., Fresko I., Hamuryudan V., Yurdakul S., Yazici H.

JOURNAL OF RHEUMATOLOGY , cilt.25, sa.11, ss.2219-2220, 1998 (SCI-Expanded, Scopus)

81. A case of rapidly progressive pulmonary aneurysm as a rare complication of Behcet's syndrome - A case report

Basak M. E., Gul S., Yazgan Y., Cankir Z., Danaci M., Demirturk L., et al.

ANGIOLOGY , cilt.49, sa.5, ss.403-408, 1998 (SCI-Expanded)

82. Clinical features of Behcet's disease in children: An international collaborative study of 86 cases

Kone-Paut I., Yurdakul S., Bahabri S., Shafae N., Ozen S., Ozdogan H., et al.

JOURNAL OF PEDIATRICS , cilt.132, sa.4, ss.721-725, 1998 (SCI-Expanded, Scopus)

83. Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome - A randomized, double-blind, placebo-controlled trial

Hamuryudan V., Mat C., Saip S., Ozyazgan Y., Siva A., Yurdakul S., et al.

ANNALS OF INTERNAL MEDICINE , cilt.128, sa.6, ss.443-451, 1998 (SCI-Expanded, Scopus)

84. Wound healing in Behcet's syndrome

Mat M. C., Nazarbaghi M., Tuzun Y., Hamuryudan V., Hızlı N., Yurdakul S., et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY , cilt.37, sa.2, ss.120-123, 1998 (SCI-Expanded)

85. Genetic anticipation in Behcet's syndrome

Fresko I., Soy M., Hamuryudan V., Yurdakul S., Yavuz S., Tumer Z., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.57, sa.1, ss.45-48, 1998 (SCI-Expanded, Scopus)

86. Topical cyclosporine-A for treatment of oral ulcers of Behcet's syndrome

Ergun T., Gurbuz O., Yurdakul S., Hamuryudan V., Bekiroglu N., Yazici H.

INTERNATIONAL JOURNAL OF DERMATOLOGY , cilt.36, sa.9, ss.720, 1997 (SCI-Expanded, Scopus)

87. Küçük damar vaskülitleri

FRESKO İ., MAT M. C., YURDAKUL S., TÜZÜNER N. N., TÜZÜN Y.

KLİNİK GELİŞİM , cilt.10, ss.199-205, 1997 (Hakemli Dergi)

88. Small vessel vasculitis and vasculitis confined to skin

Mat C., Yurdakul S., Tuzuner N. N., Tuzun Y.

BAILLIERES CLINICAL RHEUMATOLOGY , cilt.11, sa.2, ss.237-257, 1997 (SCI-Expanded, Scopus)

89. Azathioprine in Behcet's syndrome - Effects on long-term prognosis

Hamuryudan V., Ozyazgan Y., Hızlı N., Mat C., Yurdakul S., Tuzun Y., et al.

ARTHRITIS AND RHEUMATISM , cilt.40, sa.4, ss.769-774, 1997 (SCI-Expanded, Scopus)

90. Management of aneurysms in Behcet's syndrome: An analysis of 24 patients

Tuzun H. H., Besirli K., Sayin A., Vural F., Hamuryudan V., Hizli N., et al.

SURGERY , cilt.121, sa.2, ss.150-156, 1997 (SCI-Expanded, Scopus)

91. Epidemiology of Behcet's syndrome in Turkey

Tuzun Y., Yurdakul S., Ozyazgan Y., Hamuryudan V., Tuzun B., Yazici H.

INTERNATIONAL JOURNAL OF DERMATOLOGY , cilt.35, sa.9, ss.618-620, 1996 (SCI-Expanded, Scopus)

92. Calciphylaxis: A condition mimicking necrotizing vasculitis

Melikoglu M., Apaydin S., Hamuryudan V., Yurdakul S., Uygun N., Aki H., et al.

CLINICAL RHEUMATOLOGY , cilt.15, sa.5, ss.498-500, 1996 (SCI-Expanded, Scopus)

93. Paterji pozitifliğinin pikür süresi ile ilişkisi

MAT M. C., GÖKLER G., YURDAKUL S., TÜZÜN Y., YAZICI H., HAMURYUDAN V., et al.

CERRAHPAŞA TIP DERGİSİ , cilt.27, ss.94-97, 1996 (Hakemli Dergi)

94. A controlled study of reliability and validity of MRI findings in neuro-Behcet's disease

Coban O., Bahar S., AkmanDemir G., Serdaroglu P., BaykanKurt B., Tolun R., et al.

NEURORADIOLOGY , cilt.38, sa.4, ss.312-316, 1996 (SCI-Expanded, Scopus)

95. Gastrointestinal involvement in Behcet's syndrome: A controlled study

Yurdakul S., Tuzuner N., YURDAKUL I., Hamuryudan V., Yazici H.

ANNALS OF THE RHEUMATIC DISEASES , cilt.55, sa.3, ss.208-210, 1996 (SCI-Expanded, Scopus)

96. Surgical therapy of pulmonary arterial aneurysms in Behcet's syndrome

Tuzun H. H., Hamuryudan V., Yildirim S., Besirli K., Yoruk Y., Yurdakul S., et al.

ANNALS OF THORACIC SURGERY , cilt.61, sa.2, ss.733-735, 1996 (SCI-Expanded, Scopus)

97. The ten-year mortality in Behcet's syndrome

Yazici H., Başaran G., Hamuryudan V., Hızlı N., Yurdakul S., Mat C., et al.

BRITISH JOURNAL OF RHEUMATOLOGY , cilt.35, sa.2, ss.139-141, 1996 (SCI-Expanded, Scopus)

98. Seven-year follow-up of neurologic involvement in Behcet syndrome

AkmanDemir G., BaykanKurt B., Serdaroglu P., Gurvit H., Yurdakul S., Yazici H., et al.

Archives of Neurology , cilt.53, sa.7, ss.691-694, 1996 (SCI-Expanded, Scopus)

99. MORE ON HEPATITIS-C VIRUS AND BEHCETS-SYNDROME

HAMURYUDAN V., SONSUZ A., YURDAKUL S.

NEW ENGLAND JOURNAL OF MEDICINE , cilt.333, sa.5, ss.322, 1995 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

100. ANTIENDOTHELIAL CELL ANTIBODIES, ENDOTHELIAL PROLIFERATION AND VON-WILLEBRAND-FACTOR ANTIGEN IN BEHCETS-DISEASE

DIRESKENELI H., KESER G., DCRUZ D., KHAMASHTA M., AKOGLU T., YAZICI H., et al.

CLINICAL RHEUMATOLOGY , cilt.14, sa.1, ss.55-61, 1995 (SCI-Expanded, Scopus)

101. THE PREVALENCE OF SJOGRENS-SYNDROME IN BEHCETS-SYNDROME

GUNAYDIN I., USTUNDAG C., KANER G., PAZARLI H., YURDAKUL S., HAMURYUDAN V., et al.

JOURNAL OF RHEUMATOLOGY , cilt.21, sa.9, ss.1662-1664, 1994 (SCI-Expanded)

102. SYSTEMIC INTERFERON-ALPHA-2B TREATMENT IN BEHCETS-SYNDROME

HAMURYUDAN V., Moral F., YURDAKUL S., MAT C., TUZUN Y., OZYAZGAN Y., et al.

JOURNAL OF RHEUMATOLOGY , cilt.21, sa.6, ss.1098-1100, 1994 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

103. PERICARDIAL AND PULMONARY INVOLVEMENT IN RHEUMATOID-ARTHRITIS IN TURKEY

IMERYUZ N., YAZICI H., KOCAK H., ERK M., OZDER A. B., KARCIER S., et al.

CLINICAL RHEUMATOLOGY , cilt.13, sa.2, ss.239-243, 1994 (SCI-Expanded, Scopus)

104. Behçet hastalığı

YAZICI H., YURDAKUL S., TÜZÜN Y., ÖZYAZGAN Y., MAT M. C., HAMURYUDAN V.

BİLİM VE TEKNİK , sa.314, ss.25-29, 1994 (Hakemli Dergi)

105. GENITAL ULCERATION IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS

FRESKO I., YAZICI H., ISCI H., YURDAKUL S.

LUPUS , cilt.2, sa.2, ss.135, 1993 (SCI-Expanded)

106. LYMPHOCYTOTOXIC ANTIBODIES IN THE HEALTHY-CHILDREN OF PATIENTS WITH BEHCETS-SYNDROME

GUNAYDIN I., YAZICI H., OZBAKIR F., HAMURYUDAN V., YURDAKUL S.

JOURNAL OF RHEUMATOLOGY , cilt.19, sa.12, ss.1996-1998, 1992 (SCI-Expanded, Scopus)

107. M-MODE, 2-D AND DOPPLER ECHOCARDIOGRAPHIC STUDY IN 65 PATIENTS WITH BEHCETS-SYNDROME

OZKAN M., EMEL O., OZDEMIR M., YURDAKUL S., KOCAK H., OZDOGAN H., et al.

EUROPEAN HEART JOURNAL , cilt.13, sa.5, ss.638-641, 1992 (SCI-Expanded, Scopus)

108. LOW-DOSE CYCLOSPORINE-A VERSUS PULSED CYCLOPHOSPHAMIDE IN BEHCETS-SYNDROME - A SINGLE MASKED TRIAL

OZYAZGAN Y., YURDAKUL S., YAZICI H., TUZUN B., ISCIMEN A., TUZUN Y., et al.

BRITISH JOURNAL OF OPHTHALMOLOGY , cilt.76, sa.4, ss.241-243, 1992 (SCI-Expanded, Scopus)

109. INEFFICACY OF TOPICAL ALPHA-INTERFERON IN THE TREATMENT OF ORAL ULCERS OF BEHCETS-SYNDROME - A RANDOMIZED, DOUBLE-BLIND TRIAL

HAMURYUDAN V., YURDAKUL S., ROSENKAIMER F., YAZICI H.

BRITISH JOURNAL OF RHEUMATOLOGY , cilt.30, sa.5, ss.395-396, 1991 (SCI-Expanded)

110. RESPONSE TO INTRADERMAL INJECTION OF MONOSODIUM URATE CRYSTALS IN BEHCETS-SYNDROME

CAKIR N., YAZICI H., CHAMBERLAIN M., BARNES C., YURDAKUL S., ATASOY S., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.50, sa.9, ss.634-636, 1991 (SCI-Expanded, Scopus)

111. MONOZYGOTIC TWINS CONCORDANT FOR BEHCET SYNDROME

HAMURYUDAN V., YURDAKUL S., OZBAKIR F., YAZICI H., HEKIM H.

ARTHRITIS AND RHEUMATISM , cilt.34, sa.8, ss.1071-1072, 1991 (SCI-Expanded, Scopus)

112. JUVENILE CHRONIC ARTHRITIS IN A TURKISH POPULATION

OZDOGAN H. A., KASAPCOPUR O., DEDE H. Ö., ARISOY N., BECEREN T., YURDAKUL S., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.9, sa.4, ss.431-435, 1991 (SCI-Expanded)

113. DIFFUSE PROLIFERATIVE GLOMERULONEPHRITIS IN BEHCETS-SYNDROME

HAMURYUDAN V., YURDAKUL S., KURAL A., INCE U., YAZICI H.

BRITISH JOURNAL OF RHEUMATOLOGY , cilt.30, sa.1, ss.63-64, 1991 (SCI-Expanded)

114. SPLENIC SIZE IN BEHCETS-SYNDROME

SOYSAL M., DENIZCI U., ALHAN S., HAMURYUDAN V., DEDE H. Ö., YURDAKUL S., et al.

BRITISH JOURNAL OF RHEUMATOLOGY , cilt.29, sa.6, ss.497-498, 1990 (SCI-Expanded)

115. A CONTROLLED TRIAL OF AZATHIOPRINE IN BEHCETS SYNDROME

YAZICI H., Pazarlı H., Barnes C. G., TUZUN Y., OZYAZGAN Y., Silman A., et al.

NEW ENGLAND JOURNAL OF MEDICINE , cilt.322, sa.5, ss.281-285, 1990 (SCI-Expanded)

116. ANTI-YERSINIA ANTIBODIES IN PATIENTS WITH BEHCETS-DISEASE

LAHESMAARANTALA R., TOIVANEN A., GRANFORS K., YURDAKUL S., HAMURYUDAN V., YAZICI H.

ARTHRITIS AND RHEUMATISM , cilt.32, sa.11, ss.1494-1495, 1989 (SCI-Expanded, Scopus)

117. PROGNOSTIC VALUE OF HLA B5 ANTIGEN IN ISOLATED ANTERIOR UVEITIS IN BEHCETS-DISEASE

OGUZ V., Pazarlı H., OZYAZGAN Y., YAZICI H., YURDAKUL S., TUZUN Y., et al.

JOURNAL FRANCAIS D OPHTALMOLOGIE , cilt.12, ss.431-432, 1989 (SCI-Expanded)

118. Paterji testinde pikür derinliği ve dermal travma derecesinin sonuç üzerindeki isi (İntra-epidermal ve dermal paterji uygulaması)

İşçimen A., Tozakı S., SERDAROĞLU S., TÜZÜN Y., YURDAKUL S., Hamuryudan V., et al.

Deri Hast Frengi Arş , cilt.23, ss.175-181, 1989 (Hakemli Dergi)

119. THE PREVALENCE OF BEHCET SYNDROME IN A RURAL AREA IN NORTHERN TURKEY

YURDAKUL S., GÜNAYDIN İ., TUZUN Y., TANKURT N., Pazarlı H., OZYAZGAN Y., et al.

JOURNAL OF RHEUMATOLOGY , cilt.15, sa.5, ss.820-822, 1988 (SCI-Expanded, Scopus)

120. ANTIBODIES AGAINST YERSINIA, CAMPYLOBACTER, SALMONELLA, AND CHLAMYDIA IN PATIENTS WITH BEHCETS-DISEASE

TOIVANEN A., LAHESMAARANTALA R., MEURMAN O., SAPPINEN O., KOSUNEN T., YAZICI H., et al.

ARTHRITIS AND RHEUMATISM , cilt.30, sa.11, ss.1315-1317, 1987 (SCI-Expanded, Scopus)

121. HLA-B27 IN TURKISH PATIENTS WITH RHEUMATOID-ARTHRITIS

YAZICI H., SCHREUDER I., YURDAKUL S., OZBAKIR F.

ANNALS OF THE RHEUMATIC DISEASES , cilt.46, sa.9, ss.718, 1987 (SCI-Expanded)

122. SHORT-TERM CYCLOSPORINE-A TREATMENT OF BEHCETS-DISEASE

Müftüoğlu A., Pazarlı H., YURDAKUL S., YAZICI H., Ülkü B. Y., TUZUN Y., et al.

BRITISH JOURNAL OF OPHTHALMOLOGY , cilt.71, sa.5, ss.387-390, 1987 (SCI-Expanded) Sürdürülebilir Kalkınma

123. Behçet hastalığı

YAZICI H., Müftüoğlu A., YURDAKUL S., Ülkü B. Y., TÜZÜN Y., Pazarlı H.

DOĞA , cilt.11, ss.153-169, 1987 (Hakemli Dergi)

124. VONWILLEBRAND-FACTOR IN BEHCETS-SYNDROME

YAZICI H., HEKİM N., ÖZBAKIR F., YURDAKUL S., TUZUN Y., Pazarlı H., et al.

JOURNAL OF RHEUMATOLOGY , cilt.14, sa.2, ss.305-306, 1987 (SCI-Expanded)

125. OBSERVER VARIATION IN GRADING SACROILIAC RADIOGRAPHS MIGHT BE A CAUSE OF SACROILIITIS REPORTED IN CERTAIN DISEASE STATES

YAZICI H., TURUNC M., OZDOGAN H. A., YURDAKUL S., AKINCI A., BARNES C.

ANNALS OF THE RHEUMATIC DISEASES , cilt.46, sa.2, ss.139-145, 1987 (SCI-Expanded, Scopus)

126. BEHCETS-DISEASE - RELATION OF SERUM C-REACTIVE PROTEIN AND ERYTHROCYTE SEDIMENTATION-RATES TO DISEASE-ACTIVITY

Müftüoğlu A., YAZICI H., YURDAKUL S., TUZUN Y., Pazarlı H., Güngen G., et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY , cilt.25, sa.4, ss.235-239, 1986 (SCI-Expanded, Scopus)

127. SULFASALAZINE IN THE TREATMENT OF JUVENILE RHEUMATOID-ARTHRITIS - A PRELIMINARY OPEN TRIAL

OZDOGAN H. A., TURUNC M., DERINGOL B., YURDAKUL S., YAZICI H.

JOURNAL OF RHEUMATOLOGY , cilt.13, sa.1, ss.124-125, 1986 (SCI-Expanded, Scopus)

128. Behçet hastalığı: Damar tutulmasının özellikleri

Müftüoğlu A., YURDAKUL S., YAZICI H., ÖZDOĞAN H., TÜZÜN Y., Pazarlı H., et al.

BAVS VAKIF GUREBA HASTANESİ DERGİSİ , cilt.12, ss.117-124, 1985 (Hakemli Dergi)

129. Behçet hastlığı-Damar tutulmasının özellikleri

Müftüoğlu A., YURDAKUL S., YAZICI H., Ozdogan H., TÜZÜN Y., Pazarlı H., et al.

Bezm_i Alem Valide Sultan Vakıf Guraba Hastanesi Dergisi , cilt.12, ss.117-124, 1985 (Hakemli Dergi)

130. MALE-PATIENTS WITH BEHCETS SYNDROME HAVE STRONGER PATHERGY REACTIONS

YAZICI H., TUZUN Y., Tanman A. B., YURDAKUL S., SERDAROGLU S., Pazarlı H., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.3, sa.2, ss.137-141, 1985 (SCI-Expanded, Scopus)

131. INFLUENCE OF AGE OF ONSET AND PATIENTS SEX ON THE PREVALENCE AND SEVERITY OF MANIFESTATIONS OF BEHCETS SYNDROME

YAZICI H., TUZUN Y., Pazarlı H., YURDAKUL S., OZYAZGAN Y., ÖZDOĞAN H., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.43, sa.6, ss.783-789, 1984 (SCI-Expanded, Scopus)

132. A COMPARATIVE-STUDY OF THE PATHERGY REACTION AMONG TURKISH AND BRITISH PATIENTS WITH BEHCETS-DISEASE

YAZICI H., CHAMBERLAIN M., TUZUN Y., YURDAKUL S., Müftüoğlu A.

ANNALS OF THE RHEUMATIC DISEASES , cilt.43, sa.1, ss.74-75, 1984 (SCI-Expanded)

133. THE ARTHRITIS OF BEHCETS-DISEASE - A PROSPECTIVE-STUDY

YURDAKUL S., YAZICI H., TUZUN Y., Pazarlı H., YALCIN B., ALTAÇ M., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.42, sa.5, ss.505-515, 1983 (SCI-Expanded, Scopus)

134. THE VALIDITY OF THE PATHERGY TEST (NONSPECIFIC SKIN HYPERREACTIVITY) IN BEHCETS-DISEASE - A DOUBLE-BLIND-STUDY BY INDEPENDENT OBSERVERS

ALTAÇ M., TUZUN Y., YURDAKUL S., BİNYILDIZ P., YAZICI H.

ACTA DERMATO-VENEREOLOGICA , cilt.62, sa.2, ss.158-159, 1982 (SCI-Expanded, Scopus)

135. Kriyoglobulinemi: iki yöntemin kıyaslanması ve Behçet hastalığında kriyoglobulinler

ÖZBAKIR F., YAZICI H., ATAMAN N., Ülkü B. Y., Pazarlı H., TÜZÜN Y., et al.

CERRAHPAŞA TIP FAKÜLTESİ DERGİSİ , cilt.12, sa.4, ss.423-427, 1981 (Hakemli Dergi)

136. Silivri Fener köyü ve yöresinde Behçet hastalığı sıklığı ve bu hastalığın toplum içinde taranmasında kullanılabilecek bir yöntem

DEMİRHİNDİ O., YAZICI H., BİNYILDIZ P., DAYIOĞLU N., TÜZÜN Y., ALTAÇ M., et al.

CERRAHPAŞA TIP FAKÜLTESİ DERGİSİ , cilt.12, sa.4, ss.509-514, 1981 (Hakemli Dergi)

137. BEHCETS-DISEASE - LACK OF CORRELATION OF CLINICAL MANIFESTATIONS WITH HLA ANTIGENS

Müftüoğlu A., YAZICI H., YURDAKUL S., Pazarlı H., OZYAZGAN Y., TUZUN Y., et al.

TISSUE ANTIGENS , cilt.17, sa.2, ss.226-230, 1981 (SCI-Expanded)

138. OLECRANON NODULES IN A CASE OF BEHCETS-DISEASE

YURDAKUL S., YAZICI H., TUZUNER N., AYTAC S., MUFTUOGLU A. E.

ANNALS OF THE RHEUMATIC DISEASES , cilt.40, sa.2, ss.182-184, 1981 (SCI-Expanded)

139. A CONTROLLED SURVEY OF SACROILIITIS IN BEHCETS-DISEASE

YAZICI H., TUZLACI M., YURDAKUL S.

ANNALS OF THE RHEUMATIC DISEASES , cilt.40, sa.6, ss.558-559, 1981 (SCI-Expanded, Scopus)

140. USEFULNESS OF HLA DETERMINATION AND PATHERGY TEST IN THE DIAGNOSIS OF UVEITIS IN TURKEY

OZYAZGAN Y., Pazarlı H., YAZICI H., YURDAKUL S., TUZUN Y., ALTAÇ M., et al.

BRITISH JOURNAL OF OPHTHALMOLOGY , cilt.65, sa.11, ss.798-799, 1981 (SCI-Expanded, Scopus)

141. LOCALIZED MYOSITIS IN BEHCETS-DISEASE

YAZICI H., TUZUNER N. N., TUZUN Y., YURDAKUL S.

ARTHRITIS AND RHEUMATISM , cilt.24, sa.4, ss.636, 1981 (SCI-Expanded)

142. Behçet Hastalığı: I. Hematolojik ve immunolojik özellikleri

Müftüoğlu A., Ülkü B. Y., EZER G., GÜRSOY A., YAZICI H., YURDAKUL S., et al.

CERRAHPAŞA TIP FAKÜLTESİ DERGİSİ , cilt.11, sa.3, ss.347-353, 1980 (Hakemli Dergi)

143. BEHCETS DISEASE AS SEEN IN TURKEY

YAZICI H., TUZUN Y., Pazarlı H., YURDAKUL S., YALCIN B., Müftüoğlu A.

HAEMATOLOGICA , cilt.65, sa.3, ss.381-383, 1980 (SCI-Expanded, Scopus)

144. THE COMBINED USE OF HLA-B5 AND THE PATHERGY TEST AS DIAGNOSTIC MARKERS OF BEHCETS-DISEASE IN TURKEY

YAZICI H., TUZUN Y., Pazarlı H., YALCIN B., YURDAKUL S., Müftüoğlu A.

JOURNAL OF RHEUMATOLOGY , cilt.7, sa.2, ss.206-210, 1980 (SCI-Expanded)

145. HEMATOLOGICAL AND IMMUNOLOGICAL FEATURES OF BEHCETS DISEASE

YALCIN B., GÜRSOY A., EZER G., Pazarlı H., TUZUN Y., YURDAKUL S., et al.

HAEMATOLOGICA , cilt.65, sa.3, ss.390-394, 1980 (SCI-Expanded, Scopus)

146. A DOUBLE-BLIND STUDY OF COLCHICINE IN BEHCETS DISEASE

AKTULGA E., ALTAÇ M., Müftüoğlu A., OZYAZGAN Y., Pazarlı H., TUZUN Y., et al.

HAEMATOLOGICA , cilt.65, sa.3, ss.399-402, 1980 (SCI-Expanded, Scopus)

147. LEFT-VENTRICULAR ANEURYSM AND ACUTE PERICARDITIS IN A CASE OF BEHCET DISEASE

BINAK K., UCAK D., YALCIN B., TAVSANOGLU S., AYTAC S., YURDAKUL S., et al.

JOURNAL OF RHEUMATOLOGY , cilt.7, sa.4, ss.578-580, 1980 (SCI-Expanded)

148. A CASE OF WHIPPLES DISEASE COMPLICATED BY FATAL HEPATITIS

MINKARI T., PARS B., ERBENGI T., YALCIN B., AYTAC S., YURDAKUL S., et al.

HEPATO-GASTROENTEROLOGY , cilt.27, sa.4, ss.322-326, 1980 (SCI-Expanded) Sürdürülebilir Kalkınma

149. NONSPECIFIC SKIN HYPER-REACTIVITY IN BEHCETS DISEASE

TUZUN Y., ALTAÇ M., YAZICI H., BAŞÖZ A., YURDAKUL S., Pazarlı H., et al.

HAEMATOLOGICA , cilt.65, sa.3, ss.395-398, 1980 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 33

1. DRUG RETENTION RATE AND PROGNOSIS AFTER DISCONTINUATION OF INFLIXIMAB IN PATIENTS WITH BEHCET SYNDROME

Esatoglu S. N., Tukek B., Taflan S. S., Ozyazgan Y., Ucar D., Seyahi E., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1067-1068

2. Sex factor and Behçet's syndrome

YAZICI H., HEKİM N., TÜZÜN Y., SERDAROĞLU S., Kotoğyan A., ÖZ F., et al.

INTERNATIONAL CONFERENCE OF BEHÇET'S DISEASE, Birleşik Krallık, ss.205, (Tam Metin Bildiri)

3. FACTORS ASSOCIATED WITH DAMAGE PROGRESSION IN BEHCET'S SYNDROME UVEITIS

Ozyazgan Y., Ucar D., Erdogan M., Ozguler Y., Hatemi G., Yurdakul S., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1187-1188, (Özet Bildiri)

4. BIOSIMILAR INFLIXIMAB FOR BEHCET'S SYNDROME: A CASE SERIES

Dincses E., Esatoglu S. N., Ozguler Y., Uygunoglu U., Hamuryudan V., Seyahi E., et al.

19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri)

5. RELATIONSHIP BETWEEN MENSTRUATION AND SYMPTOMS OF BEHCET'S SYNDROME

Guzelant G., Ozguler Y., Esatoglu S. N., Karatemiz G., Ozdogan H., Yurdakul S., et al.

18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.92, (Özet Bildiri)

6. EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME

Guzelant G., Guzelant G., Ucar D., Hatemi G., Ozyazgan Y., Esatoglu S. N., et al.

18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.94, (Özet Bildiri)

7. Infliximab For Sight-Threatening and Refractory Uveitis Of Behcet's Syndrome

Hamuryudan V., Hatemi G., Ozyazgan Y., Ucar D., Yurdakul S., Seyahi E., et al.

77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)

8. An Outcome Survey Of 40 Patients With Budd-Chiari Syndrome Due To BEHCET'S Syndrome Followed By A Single Center

Seyahi E., Ugurlu S., Caglar E., Kantarci F., Sonsuz A., Yurdakul S., et al.

9. Aortic and Coronary Calcifications in Takayasu Arteritis

Seyahi E., Ucgul A., Ugurlu S., Akman C., Olgun D. C., Yurdakul S., et al.

Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 Kasım 2012, cilt.64

10. Management and Prognosis of Non-Pulmonary Large Arterial Disease in Behcet's Syndrome: A Reappraisal of 25 Patients From a Single Center

Tuzun H., Seyahi E., Arslan C., Hamuryudan V., Besirli K., Yazici H.

75th Annual Scientific Meeting of the American-College-of-Rheumatology/46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Illinois, Amerika Birleşik Devletleri, 4 - 09 Kasım 2011, cilt.63, (Özet Bildiri)

11. COLCHICINE DOES NOT DECREASE THE NEED FOR IMMUNOSUPPRESSIVE USE AT LONG TERM IN BEHCET'S SYNDROME

Hamuryudan V., Hatemi G., Yurdakul S., Mat C., Tascilar K., Ozyazgan Y., et al.

Conference on Excellence in Rheumatology, İstanbul, Türkiye, 17 - 19 Şubat 2011, cilt.50, (Özet Bildiri)

12. THE FREQUENCY OF FIBROMYALGIA IS NOT INCREASED AMONG NURSES

Yurdakul S., Findikoglu S. Y., Hatemi G., Suzen S., Yazici H.

Conference on Excellence in Rheumatology, İstanbul, Türkiye, 17 - 19 Şubat 2011, cilt.50, (Özet Bildiri)

13. ANTI-TNF THERAPY IN SEVERE UVEITIS OF BEHCET'S SYNDROME: REPORT OF 27 PATIENTS

Ugurlu S., Hamuryudan V., Ozyazgan Y., Seyahi E., Hatemi G., Yurdakul S., et al.

Conference on Excellence in Rheumatology, İstanbul, Türkiye, 17 - 19 Şubat 2011, cilt.50, (Özet Bildiri)

14. ANKYLOSING SPONDYLITIS ASSOCIATED WITH TAKAYASU ARTERITIS

Yildirim S., Hatemi G., Yurdakul S., Fresko I., Ozdogan H.

Conference on Excellence in Rheumatology, İstanbul, Türkiye, 17 - 19 Şubat 2011, cilt.50, (Özet Bildiri)

15. Large vessel involvement in Behcet's syndrome: A retrospective survery

Melikoglu M., UĞURLU S., Tascilar K., Caglar E., Seyahi E., Hamuryudan V., et al.

72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, San-Francisco, Kostarika, 24 - 29 Ekim 2008, cilt.58

16. Tumor necrosis factor alpha antagonists in the treatment of secondary amyloidosis.

Hatemi G., Tascilar K., Yurdakul S., Ozdogan H.

70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Washington, Kiribati, 10 - 15 Kasım 2006, cilt.54, (Özet Bildiri)

17. Fibrinolytic activity and d-dimer levels of in Behcçet’s Syndrome

YURDAKUL S., Hekim D. N., SOYSAL T., MELİKOĞLU M., ÖZBAKIR F., FRESKO İ., et al.

Annual European Congress of Rheumatology.EULAR 2003, Lizbon, Portekiz, 18 - 21 Haziran 2003, cilt.62, sa.1, ss.210-211, (Özet Bildiri)

18. Anti-Sacchcaromyces cerevisiae antibodies(ASCA) in Behçet’s

FRESKO İ., UĞURLU S., ÖZBAKIR F., ÇELİK A. F., YURDAKUL S., YAZICI H.

Annual European Congress of Rheumatology. EULAR 2003, Lizbon, Portekiz, 18 - 21 Haziran 2003, cilt.62, sa.1, ss.209

19. Anti-mycobacterial antibodies in Behçet’s syndrome.

MERT A., ÖZTÜRK R., Sipahi S., FRESKO İ., Aslan M., HAMURYUDAN V., et al.

VIIth International Conference on Behçet’s disease, Tunis, Tunus, 10 - 11 Ekim 1996, ss.25, (Özet Bildiri)

20. Vascular involvement in Behcet’s Syndrome: A controlled survey with doppler ultrasonography and CRP, FVIIIRg, ACE levels

HAMURYUDAN V., AKMAN C., ÖZBAKIR F., TÜZÜN K. H., Hızlı U., Ersavash G., et al.

VIth İnternational Conference on Behcet’s Disease, Tunus, Tunus, 10 - 11 Ekim 1996, cilt.7, ss.545, (Özet Bildiri)

21. Anti-Scl70 Antibodies in Systemic Lupus Eritematosus(SLE).

YAZICI H., ÖZBAKIR F., YURDAKUL S., ÖZDOĞAN A. H., HAMURYUDAN V., Hızlı U.

IXth EULAR Syposium of Rheumatology, Madrid, İspanya, 7 - 10 Ekim 1996, cilt.25, sa.1, ss.63, (Özet Bildiri)

22. Sm And Ro Autoantibodies in Turkish Patients with SLE and RA

Moral,MD F., ÖZBAKIR F., Çakır P. N., ÖZDOĞAN A. H., YAZICI H., YURDAKUL S., et al.

XVIIIth ILAR Congress of Rheumatology, Barselona, İspanya, 4 - 09 Temmuz 1993, cilt.20, sa.1, ss.126, (Özet Bildiri)

23. Correlation between disease actıvıty and ınterleukin-6 blood levels in systemic lupus erythematosuss, a comparative study with C3, CRP and Fibrinojen

Çakır P. N., Guerne P., Moral,MD F., ÖZBAKIR F., YURDAKUL S., ÖZDOĞAN A. H., et al.

XVIIIth ILAR Congress of Rheumatology, Barselona, İspanya, 4 - 09 Temmuz 1993, cilt.20, sa.1, ss.528, (Özet Bildiri)

24. Türk Sistemik Lupus Eritematosus ve Romatoid Artrit’lilerinde Anti-Ro ve Anti-Sm Antikorları

Moral, U. F., ÖZBAKIR F., Çakır P. N., HAMURYUDAN V., YURDAKUL S., ÖZDOĞAN A. H., et al.

VIII. Ulusal Romatoloji Kongresi, İstanbul, Türkiye, 7 - 11 Eylül 1992, cilt.8, ss.14, (Özet Bildiri)

25. Lymphocytotoxic Antibodies (LCA) in Family Members of Patients with Behcet’s Syndrome (BS)

Günaydın İ., YAZICI H., ÖZBAKIR F., HAMURYUDAN V., YURDAKUL S.

12th European Congress of Rheumatology, Budabeşte, Macaristan, 30 Haziran - 06 Temmuz 1991, cilt.32, ss.135, (Özet Bildiri)

26. Behçet Sendromlu Tek Yumurta İkizleri

HAMURYUDAN V., YURDAKUL S., Hekim D. N., ÖZBAKIR F., YAZICI H.

VII. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 30 Ekim - 01 Kasım 1990, cilt.6, ss.30, (Özet Bildiri)

27. Behcet Hastaları ve Aile Bireylerinde Lenfositotoksik Antikorlar

Günaydın, U. İ., YAZICI H., ÖZBAKIR F., HAMURYUDAN V., YURDAKUL S.

VII. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 30 Ekim - 01 Kasım 1990, cilt.6, ss.44

28. HLA antigens in recurrent oral ulceration; Evidence aganist a common disease spectrum with Behçet’s syndrome

ÖZBAKIR F., YAZICI H., MAT M. C., TÜZÜN Y., YURDAKUL S., YILMAZER S.

XIth European Congress of Rheumatology Congress, Atina, Yunanistan, 28 Haziran - 04 Temmuz 1987, cilt.5, sa.2, ss.140

29. Rekkuran Aftöz Stomatitde Doku Antijenler

ÖZBAKIR F., MAT M. C., YURDAKUL S., TÜZÜN Y., YAZICI H.

VIII. Ulusal İmmünoloji Kongresi, İstanbul, Türkiye, 30 - 31 Ekim 1986, cilt.7, ss.9, (Özet Bildiri)

30. Romatoid Artritte Pulse Siklofosfamid Tedavisi

Dede U. H., YURDAKUL S., ÖZBAKIR F., YAZICI H.

VIII. Ulusal İmmünoloji Kongresi, İstanbul, Türkiye, 30 Eylül - 01 Kasım 1986, cilt.1, ss.28, (Özet Bildiri)

31. Total lymphoid irradiation for the treatment of intractable Behçet's syndrome

YURDAKUL S., YAZICI H., Müftüoğlu A., OKKAN S., TURKAN S., UZEL R., et al.

INTERNATIONAL CONFERENCE ON BEHÇET'S DISEASE, Londra, Birleşik Krallık, 5 - 06 Eylül 1985, ss.307-308, (Tam Metin Bildiri)

32. Sex factor and Behçet's syndrome

YAZICI H., HEKİM N., TÜZÜN Y., SERDAROĞLU S., Kotoğyan A., ÖZ F., et al.

INTERNATIONAL CONFERENCE OF BEHÇET'S DISEASE, Londra, Birleşik Krallık, 5 - 06 Eylül 1985, ss.205-206

33. The prevalence of HLA B27 is Increased in Rheumatoid Arthritis in Turkey

YAZICI H., ÖZBAKIR F., YURDAKUL S., Müftüoğlu P. A.

5th. European İmmunology Meeting, İstanbul, Türkiye, 1 - 04 Haziran 1982, cilt.5, sa.33, ss.213, (Özet Bildiri)

Kitaplar 4

Metrikler

Yayın

186

Yayın (WoS)

153

Yayın (Scopus)

134

Atıf (WoS)

6818

H-İndeks (WoS)

Atıf (Scopus)

7078

H-İndeks (Scopus)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler